Keren Abecassis

Title: Keren Abecassis: Innovator in Morpholino Compounds

Introduction

Keren Abecassis is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of pharmaceutical sciences, particularly through her innovative work on morpholino compounds. Her research focuses on the development of compounds that can be used in the treatment of various neurological and neurodegenerative diseases.

Latest Patents

Keren Abecassis holds a patent for "Morpholino compounds, uses and methods." This invention relates to morpholino-derivatives according to a specific formula, including their stereoisomers and pharmaceutically acceptable salts or solvates. The compounds serve as antagonists, reverse agonists, or agonists of G-protein coupled receptors, such as dopamine D4 and 5HT1a. The patent also covers pharmaceutical compositions that include these compounds and methods for their use. These innovations may be particularly beneficial in treating diseases and disorders, as well as in the design and selection of further therapeutic compounds.

Career Highlights

Keren Abecassis is affiliated with the University of Dundee, where she continues her research and development efforts. Her work has garnered attention for its potential impact on therapeutic strategies for complex diseases.

Collaborations

Keren has collaborated with notable colleagues, including Jeremy Besnard and Andrew Lee Hopkins, to advance her research initiatives. Their combined expertise contributes to the innovative approaches in the field of pharmaceutical development.

Conclusion

Keren Abecassis is a pioneering inventor whose work on morpholino compounds holds promise for advancing treatments for neurological disorders. Her contributions to the field exemplify the importance of innovation in pharmaceutical sciences.